How does Insulin Human AF differ from animal-derived insulin
What is Insulin Human AF and how does it differ from animal-derived insulin? Insulin Human AF, also known as recombinant insulin, consists of human insulin crystals – a biosynthetic product produced by recombinant microbial expression in yeast.
The yeast organism used to produce our recombinant insulin does not contain genes or express antigens of livestock or poultry disease agents. It is neither stored nor grown in media containing animal raw material. This means that our Insulin Human AF supports major growth media suppliers’ definition for an animal-free product.
Our Insulin Human AF is considered to be virologically safe, with a negligible risk of transferring BSE agents to the media or reagents in which our insulin is a component. With our Insulin Human AF, you also avoid the risk of impurities such as mycoplasmas, which can pass line to line from the upstream bioreactor and contaminate your whole line.
Insulin Human AF is a key component in serum-free growth media for mammalian cells. Ideal for manufacturing monoclonal antibodies, virus vaccines, gene therapy products and other biological drug products, it stimulates the proliferation of cells and enhances the yield.